Which will be much easier to judge when all the data is gone through in the coming months. Once again trial was set up as exploratory for dose and length and did meet primary FDA agreed upon endpoints. Information forthcoming will be used to design phase 3 in conjunction with FDA. Significance was expounded upon in investors call. I can understand the questioning but proof in the pudding will be phase 3.
News 
Market Data 
Discover 
AI
